Stocks and Investing
Stocks and Investing
Thu, February 16, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mason Carrico Reiterated (CDNA) at Buy and Held Target at $19 on, Feb 16th, 2023
Mason Carrico of Stephens & Co., Reiterated "CareDx, Inc" (CDNA) at Buy and Held Target at $19 on, Feb 16th, 2023.
Mason has made no other calls on CDNA in the last 4 months.
There are 3 other peers that have a rating on CDNA. Out of the 3 peers that are also analyzing CDNA, 0 agree with Mason's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Mason
- Matthew Sykes of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $29 on, Monday, February 6th, 2023
- Andrew Cooper of "Raymond James" Maintained at Strong Buy with Decreased Target to $24 on, Tuesday, January 31st, 2023
- Mark Massaro of "BTIG" Maintained at Strong Buy with Decreased Target to $28 on, Monday, November 7th, 2022
Contributing Sources